We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47

Product News   Feb 28, 2011

 
Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Scientists Demonstrate Sensitivity and Reliability of Droplet Digital PCR in Clinical Oncology at AACR 2020

Product News

Scientists presented more than 45 abstracts that demonstrated the value of Bio-Rad’s Droplet Digital PCR (ddPCR) technology as a tool for quantifying cancer biomarkers at the American Association for Cancer Research (AACR) annual meeting.

READ MORE

Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Product News

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

READ MORE

Thermo Fisher Expands GlobalAccess Sequencing Program to Oncology Labs

Product News

The company has extended program benefits to oncology laboratories and fast-tracking access to comprehensive molecular profiling on the Genexus System.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE